2024/4/24 -Roche Late Stage Product Development. RG6538. P-BCMA-ALLO1. multiple myeloma (MM). Description/ Summary: P-BCMA-ALLO1 (RG6538) is an off-the-shelf, donor ...
2024/4/1 -Key Statistics. P/E Ratio 17.62. PEGY Ratio 3.15. Shares Outstanding 702.563M. Price to Book Ratio 6.89. Price to Sales Ratio 3.45. 1 Year Return –4.57%. 30 Day ...
1日前 -Anchor/Host/Reporter WBZ-TV/Patriots 5th Quarter/Gameday/All-Access; Wedding Officiant; 98-Mile Champion; SU alum; Proud Dad.
2024/2/27 -P/E Ratio 17.71; EPS CHF14.30; Yield 3.79%; Dividend CHF9.60; Ex-Dividend Date Mar 14, 2024; Short Interest N/A; % of Float Shorted N/A; Average Volume 1.38M ...
2024/2/3 -The Elecsys Phospho-Tau (181P) CSF assay is an in vitro diagnostic immunoassay intended for the quantitative determination of the phosphorylated Tau protein in ...
4日前 -Senior Master, Merchant Marine. Ex-Navy/Army Reservist; Maritime Analyst interested in Defence.
2024/5/1 -... Twitter · Live Video Broadcasts · Photo Galleries · Mental Health Awareness ... Dunn singled, advanced to second on an error by p, RBI; M. Stonbrake scored ...
2024/2/2 -... Twitter · Facebook · LinkedIn · Instagram · Youtube. Rachel Roche. Associate Director ... Contact. P: 909-748-8884. A-Z Directory · Jeff Martinez · Rachel Roche.
2024/3/23 -The main aim of this study was, therefore, to investigate if tau phosphorylation at threonine-212 is an indicator of AD neuropathology, to develop and validate ...
2024/1/3 -Clinical stage biotechnology company, Remix Therapeutics announces collaboration and licensing agreement with Roche for the discovery and development of ...